Abstract-The
cross-reactivity of mouse anti-benzylpenicilloyl antibodies against cephalothin-haptens and cephalothin-polymers was divergent depending on the source and isotype of antibodies and the methods to raise them. High cross reactivity nearly equal to the reactivity to homologous haptens and polymers was obtained only with the IgE antibody of C57BL/6J mouse raised shortly after an immunizing injection of the emulsion containing Freund's complete adjuvant and benzylpenicilloyl-bovine r-globulin conjugate.
With the other antibody preparations, cross-reactivity was moderate to negligible. The protein conjugates of penicillin G (PCG) or CET used in the present study were prepared according to Levine and Ovary (7), and their hapten contents were determined by the technique of Ebata et al. (8) . They are as follows: BP031-BGG (BGG: bovine r globulin, Sigma), BPO10-GpSA (GpSA: guinea pig serum albumin, Sigma) and CET14 GpSA. BP031-BGG was used as the im munogen, and the two GpSA conjugates were employed as PCA elicitors. Polymers of PCG and CET were isolated from their aged aqueous solutions by gel filtration using Sephadex G 25 (Fine, Pharmacia) and used as elicitors.
Details for isolating these polymeric materials are described elsewhere (9).
To raise anti-BPO antibodies, C57BL/ 6JShi and C3H/HeShi mice (females, 7 to 9 weeks old) were immunized against BP031 BGG conjugate by (1) two or three intra peritoneal injections at one-week intervals of 1 ug of the immunogen adsorbed to 1 mg of aluminum hydroxide gel or (2) a single or two intraperitoneal injections at two weeks apart of FCA (Freund's complete adjuvant, Difco) emulsion containing 1 mg of the immunogen. After various time intervals, the animals were bled by heart puncture, and antisera from a group of five mice were pooled. The cross-reactivity of anti-BPO IgE antibodies thus produced against CET haptens or polymers was determined by 18-hr PCA in Wistar/Shi rats (females, 7 to 9 weeks old) and DS/Shi mice (females, 7 to 9 weeks old), while cross-reactivity of IgG1 anti bodies was assayed by 1 -hr PCA in DS/Shi mice using antisera heat-inactivated at 56°C for 1 hr. PCA tests in rats and mice were done in duplicate using two recipients for each antiserum, and the results were ex pressed in terms of the geometric mean of the titers, i.e., the highest dilutions to mediate minimal (5 mm in diameter) bluing. The difference between the two recipients was minimal, if any, showing at most only one degree of difference with two-fold serial dilution.
As shown in Table 1 , high cross-reactivity against CET14-GpSA conjugate was observed only with the IgE antibodies of five different serum pools (Pools 1 to 5) from C57BL/6JShi mice obtained 6 or 7 days after one injection of BP031-BGG emulsified with FCA, the titers against the CET con jugate being lower only by one or two degrees of the two-fold dilution than those against the homologous conjugate. This was the case with both PCA tests in rats and mice. Because unconjugated GpSA did not elicit PCA (data not shown), the PCA observed was produced by the interaction of anti-BPO antibodies with BPO or CET-haptens. However, after a booster immunization, anti BPO IgE antibodies from C57BL/6JShi mice (Pools 6 and 7) did not cross-react with CET14-GpSA, though the antibody titer against BP010-GpSA was also reduced considerably. Anti-BPO IgE antibodies raised in C3H/HeShi mice by one or two injections of the FCA emulsion containing BP031 BGG did not cross-react with the CET conjugate.
In this mouse strain which is a high responder to BGG, both anti-BPO IgE and IgGI antibodies were also produced by repeated injections of minute amounts of the alum-precipitated BP031-BGG. The IgE anti bodies thus raised cross-reacted moderately with the CET conjugate, the titers being three or four degrees lower than those against the homologous elicitor. Again, anti-BPO IgGI antibodies were less cross-reactive than the IgE antibodies in the same serum batch (Table 1) . Table 1 . Cross-reactivity of mouse anti-BPO antibodies with CET14-GpSA conjugate Table 2 . Cross-reactivity to PCG or CET-polymers of anti-BPO IgE antibodies produced in C57BL/ 6JShi mice short!y after a single injection of FCA emulsion containing BP031.BGG As shown in Table  2 , anti-BPO IgE antibodies in the C57BL/6JShi antiserum prepared shortly after one immunizing in jection also could react with polymeric materials of CET as well as with those of PCG. All the other antisera did not mediate PCA when either PCG or CET-polymers were intravenously challenged (data not shown).
Rabbit anti-BPO IgG antibodies are highly cross-reactive with CET haptens (1, 2). We obtained similar results with anti-BPO IgG1 antibodies of guinea pig origin (M. Harada et al., unpublished observation).
However, our present study demonstrated that antibodies produced in the mouse in response to BP031 BGG vary widely in their cross-reactivity de pending on such factors as the mouse strain, antibody isotype and the method used to raise the antibodies. Therefore, no generalized con cept can be proposed for the cross-reactivity between PCG and CET. The divergency observed with the mouse antibodies might be related in some way to clinical findings that CET provokes an adverse allergic effect in some of the PCG-hypersensitive patients but not in others (10-13).
